Novo Nordisk: Buy Hand Over Fist While Others Panic [Seeking Alpha]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Seeking Alpha
NVO's valuation is compelling, with a P/E of 10.42 and FCF yield above 5.2%, while its dividend yield has reached a decade high of ~4.9%. Strategic pivots include a promising triple G agonist (UBT251), a digital partnership with Hims, and pipeline expansion into MASH and heart failure. Key risks include FDA warning letter, margin compression from TrumpRx and low-cost pills, and competitive pressure from Eli Lilly's superior efficacy and growth outlook. Douglas Cliff/iStock Editorial via Getty Images Introduction I've been holding and covering Novo Nordisk's ( NVO ) stock for a while now, and I sure was not expecting such a volatile period for the Danish pharmaceutical giant. Since my This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of NVO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from S
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- HSBC downgrades Eli Lilly, says shares are ‘priced to perfection' [Yahoo! Finance]Yahoo! Finance
- Rival GLP-1 pill matches Wegovy weight loss data, adding to competitive pressure on Novo Nordisk [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk A/S Investigated by the Portnoy Law FirmGlobeNewswire
- The Donroe Doctrine Is Coming For Cuba [Seeking Alpha]Seeking Alpha
- Yahoo Finance [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 3/17/26 - Form 6-K
- 3/9/26 - Form 6-K
- 3/2/26 - Form 6-K
- NVO's page on the SEC website